Morgan Stanley Amends Artivion Stake as of Dec 31, 2023
Ticker: AORT · Form: SC 13G/A · Filed: Feb 12, 2024 · CIK: 784199
| Field | Detail |
|---|---|
| Company | Artivion, Inc. (AORT) |
| Form Type | SC 13G/A |
| Filed Date | Feb 12, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, form-13g, medical-devices
TL;DR
**Morgan Stanley still holds Artivion shares, signaling institutional confidence.**
AI Summary
Morgan Stanley filed an amended SC 13G/A on February 12, 2024, indicating its ownership of Artivion, Inc. (formerly CryoLife Inc.) common stock as of December 31, 2023. This filing, an amendment to a previous disclosure, shows Morgan Stanley's position as a significant institutional investor in the surgical and medical instruments company. For investors, this matters because large institutional holdings like Morgan Stanley's can signal confidence in the company's long-term prospects and potentially influence stock stability.
Why It Matters
This filing confirms Morgan Stanley's continued significant institutional ownership in Artivion, Inc., which can be a positive signal for other investors and contribute to market stability for the stock.
Risk Assessment
Risk Level: low — This is a routine amendment filing by a large institution, indicating no immediate negative or highly volatile changes.
Analyst Insight
Investors should note Morgan Stanley's continued institutional presence in Artivion, Inc. and consider it as part of their broader due diligence, but this filing alone doesn't suggest an immediate buy or sell action.
Key Players & Entities
- Morgan Stanley (company) — filing an amendment to its ownership stake
- ARTIVION, INC. (company) — the subject company whose common stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- CryoLife Inc (company) — Artivion, Inc.'s former name
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'Amendment No.1' sections.
Who is the subject company of this filing?
The subject company is ARTIVION, INC., with a Central Index Key (CIK) of 0000784199, as indicated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ARTIVION, INC.'
Who filed this SC 13G/A amendment?
This SC 13G/A amendment was filed by MORGAN STANLEY, with a Central Index Key (CIK) of 0000895421, as stated under 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MORGAN STANLEY'.
What was the date of the event that required this filing?
The date of the event which required this filing was December 31, 2023, as specified under '(Date Of Event which Requires Filing of this Statement)'.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by the '[x] Rule 13d-1(b)' checkbox selection.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 12, 2024 regarding ARTIVION, INC. (AORT).